Literature DB >> 16327981

Expression patterns among interferon regulatory factor-1, human X-box binding protein-1, nuclear factor kappa B, nucleophosmin, estrogen receptor-alpha and progesterone receptor proteins in breast cancer tissue microarrays.

Yuelin Zhu1, Baljit Singh, Stephen Hewitt, Aiyi Liu, Bianca Gomez, Antai Wang, Robert Clarke.   

Abstract

Interferon regulatory factor-1 (IRF-1), human X-box binding protein-1 (hXBP-1), nuclear factor kappa B p65 (NFkappaB p65) and nucleophosmin (NPM) have been implicated in a signaling network of endocrine responsiveness. Expression of these proteins was measured by immunohistochemistry in tissue microarrays of 54 breast tumors. Correlations between each protein and established prognostic markers were assessed by Spearman's rank order correlation coefficient and partial correlation coefficient analyses. Moderate/strong staining is seen for hXBP-1 (79% of tumors) and NFkappaB p65 (57%). NPM exhibits nuclear staining (95%); IRF-1 exhibits both cytosolic (IRF-1c; 90%) and nuclear staining (IRF-1n; 51%). IRF-1c is associated with age (p=0.034); IRF-1n and PgR expression are correlated (p=0.014). NFkappaB p65 shows a borderline association with S phase (p=0.062). Coexpression of IRF-1c and hXBP1 (p=0.001), IRF-1c and NFkappaB (p=0.002), and hXBP-1 and NFkappaB (p=0.018) is observed. An inverse correlation exists between IRF-1n and NFkappaB (p=0.034). All four proteins are detected in breast tumors and their expression patterns support their role(s) in a key signaling network.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16327981

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  22 in total

1.  IFNgamma restores breast cancer sensitivity to fulvestrant by regulating STAT1, IFN regulatory factor 1, NF-kappaB, BCL2 family members, and signaling to caspase-dependent apoptosis.

Authors:  Yanxia Ning; Rebecca B Riggins; Jennifer E Mulla; Haniee Chung; Alan Zwart; Robert Clarke
Journal:  Mol Cancer Ther       Date:  2010-05       Impact factor: 6.261

2.  NF-κB signaling is required for XBP1 (unspliced and spliced)-mediated effects on antiestrogen responsiveness and cell fate decisions in breast cancer.

Authors:  Rong Hu; Anni Warri; Lu Jin; Alan Zwart; Rebecca B Riggins; Hong-Bin Fang; Robert Clarke
Journal:  Mol Cell Biol       Date:  2014-11-03       Impact factor: 4.272

Review 3.  Biological determinants of endocrine resistance in breast cancer.

Authors:  Elizabeth A Musgrove; Robert L Sutherland
Journal:  Nat Rev Cancer       Date:  2009-09       Impact factor: 60.716

4.  ATM gene alterations in chronic lymphocytic leukemia patients induce a distinct gene expression profile and predict disease progression.

Authors:  Anna Guarini; Marilisa Marinelli; Simona Tavolaro; Emanuele Bellacchio; Monia Magliozzi; Sabina Chiaretti; Maria Stefania De Propris; Nadia Peragine; Simona Santangelo; Francesca Paoloni; Mauro Nanni; Ilaria Del Giudice; Francesca Romana Mauro; Isabella Torrente; Robin Foà
Journal:  Haematologica       Date:  2011-10-11       Impact factor: 9.941

5.  Interferon regulatory factor-1 signaling regulates the switch between autophagy and apoptosis to determine breast cancer cell fate.

Authors:  Jessica L Schwartz-Roberts; Katherine L Cook; Chun Chen; Ayesha N Shajahan-Haq; Margaret Axelrod; Anni Wärri; Rebecca B Riggins; Lu Jin; Bassem R Haddad; Bhaskar V Kallakury; William T Baumann; Robert Clarke
Journal:  Cancer Res       Date:  2015-01-09       Impact factor: 12.701

Review 6.  The role of X-box binding protein-1 in tumorigenicity.

Authors:  Ayesha N Shajahan; Rebecca B Riggins; Robert Clarke
Journal:  Drug News Perspect       Date:  2009-06

7.  Gene network signaling in hormone responsiveness modifies apoptosis and autophagy in breast cancer cells.

Authors:  Robert Clarke; Ayesha N Shajahan; Rebecca B Riggins; Younsook Cho; Anatasha Crawford; Jianhua Xuan; Yue Wang; Alan Zwart; Ruchi Nehra; Minetta C Liu
Journal:  J Steroid Biochem Mol Biol       Date:  2009-03       Impact factor: 4.292

8.  Frequent loss of heterozygosity at the interferon regulatory factor-1 gene locus in breast cancer.

Authors:  Luciane R Cavalli; Rebecca B Riggins; Antai Wang; Robert Clarke; Bassem R Haddad
Journal:  Breast Cancer Res Treat       Date:  2009-08-21       Impact factor: 4.872

9.  Estrogen stimulates the proliferation of human endometrial cancer cells by stabilizing nucleophosmin/B23 (NPM/B23).

Authors:  Angel Chao; Chiao-Yun Lin; Chia-Lung Tsai; Swei Hsueh; Ying-Yu Lin; Cheng-Tao Lin; Hung-Hsueh Chou; Tzu-Hao Wang; Chyong-Huey Lai; Hsin-Shih Wang
Journal:  J Mol Med (Berl)       Date:  2012-08-29       Impact factor: 4.599

Review 10.  Endocrine resistance in breast cancer--An overview and update.

Authors:  Robert Clarke; John J Tyson; J Michael Dixon
Journal:  Mol Cell Endocrinol       Date:  2015-10-09       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.